Shenzhen - Delayed Quote CNY

Guangdong Transtek Medical Electronics Co., Ltd (300562.SZ)

8.25 -0.01 (-0.12%)
At close: 3:04 PM GMT+8
Loading Chart for 300562.SZ
DELL
  • Previous Close 8.26
  • Open 9.12
  • Bid 8.24 x --
  • Ask 8.25 x --
  • Day's Range 8.08 - 8.37
  • 52 Week Range 5.94 - 13.00
  • Volume 5,111,399
  • Avg. Volume 9,929,560
  • Market Cap (intraday) 1.789B
  • Beta (5Y Monthly) 0.35
  • PE Ratio (TTM) 51.56
  • EPS (TTM) 0.16
  • Earnings Date --
  • Forward Dividend & Yield 0.01 (0.12%)
  • Ex-Dividend Date Jun 9, 2023
  • 1y Target Est --

Guangdong Transtek Medical Electronics Co., Ltd provides smart wearables and mobile medical care products in China and internationally. The company offers wearable sports bracelets and watches, electronic health scales, fat measuring instruments, electronic blood pressure monitors, and other hardware devices. It also provides integrated software and intelligent hardware solutions for sports slimming, chronic disease management, and other fields. Guangdong Transtek Medical Electronics Co., Ltd was founded in 2002 and is based in Zhongshan, China.

www.lifesense.com

1,286

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 300562.SZ

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300562.SZ
27.70%
SSE Composite Index
3.04%

1-Year Return

300562.SZ
22.16%
SSE Composite Index
9.67%

3-Year Return

300562.SZ
49.80%
SSE Composite Index
10.55%

5-Year Return

300562.SZ
36.21%
SSE Composite Index
5.69%

Compare To: 300562.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300562.SZ

Valuation Measures

As of 4/18/2024
  • Market Cap

    1.79B

  • Enterprise Value

    1.25B

  • Trailing P/E

    51.72

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.01

  • Price/Book (mrq)

    1.72

  • Enterprise Value/Revenue

    1.41

  • Enterprise Value/EBITDA

    18.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.89%

  • Return on Assets (ttm)

    0.57%

  • Return on Equity (ttm)

    3.08%

  • Revenue (ttm)

    884.26M

  • Net Income Avi to Common (ttm)

    34.37M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    677.67M

  • Total Debt/Equity (mrq)

    13.18%

  • Levered Free Cash Flow (ttm)

    36.95M

People Also Watch